Frenolicin B is a polyketide antibiotic produced by the bacterium Streptomyces roseofulvus, known for its broad-spectrum antimicrobial activity against Gram-positive bacteria and its potential antitumor… Read more
Frenolicin B is a polyketide antibiotic produced by the bacterium Streptomyces roseofulvus, known for its broad-spectrum antimicrobial activity against Gram-positive bacteria and its potential antitumor properties. As a significant research compound, it is utilized to study mechanisms of bacterial inhibition and investigate its specific effects in oncology. Laboratories rely on high-quality reference standards of Frenolicin B API to support precise analytical testing and method validation. This category also encompasses essential non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds required for comprehensive impurity profiling. These related substances are critical in pharmaceutical research and quality control, enabling scientists to monitor degradation pathways, accurately quantify levels during stability studies, and ensure the reliability of experimental data involving this structurally complex molecule.